|Articles|October 1, 2011
- BioPharm International-10-02-2011
- Volume 2011 Supplement
- Issue 7
BioPharm International, October 2011 Supplement
Advances in Vaccine Technologies
Advertisement
Articles in this issue
over 14 years ago
Challenges and Trends in Vaccine Manufacturingover 14 years ago
DNA Vaccine DeliveryNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
How Biopharma Navigates the 2026 Economic Shift
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
5
